ALDER BIOPHARMACEUTICALS INC Research and Development Expense
ALDER BIOPHARMACEUTICALS INC reported Research and Development Expense of $34.13 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2019-08-06
- ALDER BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2019-06-30 was $34.13M, a 35.39% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2019-03-31 was $69.59M, a 6.02% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2018-12-31 was $64.45M, a 44.02% increase year-over-year.
- ALDER BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2018-09-30 was $47.79M, a 8.42% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC research and development expense for fiscal 2018 was $239.11M, a 5.45% decline from fiscal 2017.
- ALDER BIOPHARMACEUTICALS INC research and development expense for fiscal 2017 was $252.90M, a 90.50% increase from fiscal 2016.
- ALDER BIOPHARMACEUTICALS INC research and development expense for fiscal 2016 was $132.76M, a 90.72% increase from fiscal 2015.
- ALDER BIOPHARMACEUTICALS INC research and development expense for fiscal 2015 was $69.61M, a 108.17% increase from fiscal 2014.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $34.13M 10-Q · filed 2019-08-06 | $103.71M 10-Q · filed 2019-08-06 | $168.16M derived: sum of 3 quarters · filed 2019-08-06 | $215.96M derived: sum of 4 quarters · filed 2019-08-06 |
| 2019-03-31 | $69.59M 10-Q · filed 2019-05-02 | $134.04M derived: sum of 2 quarters · filed 2019-05-02 | $181.83M derived: sum of 3 quarters · filed 2019-05-02 | $234.65M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-12-31 | $64.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $112.24M derived: sum of 2 quarters · filed 2019-02-25 | $165.06M derived: sum of 3 quarters · filed 2019-08-06 | $239.11M 10-K · filed 2019-02-25 |
| 2018-09-30 | $47.79M 10-Q · filed 2018-11-05 | $100.61M derived: sum of 2 quarters · filed 2019-08-06 | $174.66M 10-Q · filed 2018-11-05 | $219.41M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-06-30 | $52.82M 10-Q · filed 2019-08-06 | $126.87M 10-Q · filed 2019-08-06 | $171.62M derived: sum of 3 quarters · filed 2019-08-06 | $223.80M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $74.05M 10-Q · filed 2019-05-02 | $118.80M derived: sum of 2 quarters · filed 2019-05-02 | $170.99M derived: sum of 3 quarters · filed 2019-05-02 | $236.26M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $44.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $96.94M derived: sum of 2 quarters · filed 2019-02-25 | $162.21M derived: sum of 3 quarters · filed 2019-02-25 | $252.90M 10-K · filed 2019-02-25 |
| 2017-09-30 | $52.19M 10-Q · filed 2018-11-05 | $117.46M derived: sum of 2 quarters · filed 2018-11-05 | $208.15M 10-Q · filed 2018-11-05 | $249.94M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $65.28M 10-Q · filed 2018-08-07 | $155.97M 10-Q · filed 2018-08-07 | $197.75M derived: sum of 3 quarters · filed 2019-02-25 | $227.25M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $90.69M 10-Q · filed 2018-05-08 | $132.48M derived: sum of 2 quarters · filed 2019-02-25 | $161.97M derived: sum of 3 quarters · filed 2019-02-25 | $195.80M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $41.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $71.28M derived: sum of 2 quarters · filed 2019-02-25 | $105.11M derived: sum of 3 quarters · filed 2019-02-25 | $132.76M 10-K · filed 2019-02-25 |
| 2016-09-30 | $29.49M 10-Q · filed 2017-11-07 | $63.32M derived: sum of 2 quarters · filed 2017-11-07 | $90.97M 10-Q · filed 2017-11-07 | $112.61M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $33.83M 10-Q · filed 2017-08-08 | $61.48M 10-Q · filed 2017-08-08 | $83.12M derived: sum of 3 quarters · filed 2018-02-26 | $105.97M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $27.65M 10-Q · filed 2017-04-27 | $49.28M derived: sum of 2 quarters · filed 2018-02-26 | $72.14M derived: sum of 3 quarters · filed 2018-02-26 | $86.22M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $21.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $44.49M derived: sum of 2 quarters · filed 2018-02-26 | $58.58M derived: sum of 3 quarters · filed 2018-02-26 | $69.61M 10-K · filed 2018-02-26 |
| 2015-09-30 | $22.85M 10-Q · filed 2016-10-27 | $36.94M derived: sum of 2 quarters · filed 2016-10-27 | $47.98M 10-Q · filed 2016-10-27 | $57.97M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $14.09M 10-Q · filed 2016-07-26 | $25.12M 10-Q · filed 2016-07-26 | $35.12M derived: sum of 3 quarters · filed 2017-02-23 | $42.16M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $11.04M 10-Q · filed 2016-04-28 | $21.03M derived: sum of 2 quarters · filed 2017-02-23 | $28.08M derived: sum of 3 quarters · filed 2017-02-23 | $37.45M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $17.04M derived: sum of 2 quarters · filed 2017-02-23 | $26.42M derived: sum of 3 quarters · filed 2017-02-23 | $33.44M 10-K · filed 2017-02-23 |
| 2014-09-30 | $7.05M 10-Q · filed 2015-11-05 | $16.42M derived: sum of 2 quarters · filed 2015-11-05 | $23.44M 10-Q · filed 2015-11-05 | $29.78M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $9.38M 10-Q · filed 2015-08-05 | $16.40M 10-Q · filed 2015-08-05 | $22.73M derived: sum of 3 quarters · filed 2016-02-23 | $31.65M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $7.02M 10-Q · filed 2015-05-07 | $13.35M derived: sum of 2 quarters · filed 2016-02-23 | $22.28M derived: sum of 3 quarters · filed 2016-02-23 | $30.42M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $15.26M derived: sum of 2 quarters · filed 2016-02-23 | $23.40M derived: sum of 3 quarters · filed 2016-02-23 | $31.88M 10-K · filed 2016-02-23 |
| 2013-09-30 | $8.92M 10-Q · filed 2014-11-03 | $17.07M derived: sum of 2 quarters · filed 2014-11-03 | $25.55M 10-Q · filed 2014-11-03 | |
| 2013-06-30 | $8.14M 10-Q · filed 2014-08-05 | $16.63M 10-Q · filed 2014-08-05 | ||
| 2013-03-31 | $8.48M 10-Q · filed 2014-06-20 | |||
| 2012-12-31 | $30.67M 10-K · filed 2015-03-13 |